p.s. VIR’s CEO is George Scangos of BIIB/EXEL fame. Despite a small bump today related to coronavirus (https://finance.yahoo.com/news/vir-biotechnology-applying-multiple-platforms-224510804.html ), VIR is down about 30% from its Oct 2019 IPO (#msg-151648189).